The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease
Open accessAbstract
UNLABELLED: Previous studies examining the relationship between hepatic iron deposition and histological severity in nonalcoholic fatty liver disease (NAFLD) have been inconclusive. The goal of this study was to examine the relationship between hepatic iron deposition and liver histology in 849 patients enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network. Hepatic iron staining was performed in a central laboratory, and the stains were scored for grade and cellular and parenchymal localization by a central pathology committee; the relationship between the grade and pattern of iron deposition and the clinical, laboratory, and histological variables was examined with univariate and multivariate analyses. Stainable hepatic iron was present in 293 of 849 patients (34.5%) in one of three histological patterns: a hepatocellular (HC) pattern [63/849 (7.4%)], a reticuloendothelial system (RES) cell pattern [91/849 (10.7%)], or a mixed RES/HC pattern [139/849 (16.4%)]. Patients with the RES iron-staining pattern were more likely to have advanced fibrosis compared to those with those with HC iron (P = 0.01). Patients with RES iron were also more likely to have advanced histological features such as fibrosis (P = 0.049), portal inflammation (P = 0.002), HC ballooning (P = 0.006), and definite nonalcoholic steatohepatitis (P = 0.007) compared to those with patients with HC or mixed iron patterns. The presence of RES iron (odds ratio = 1.60, 95% confidence interval = 1.10-2.33, P = 0.015) was independently associated with advanced hepatic fibrosis on multiple regression analysis after adjustments for age, gender, diabetes status, and body mass index. CONCLUSION: The presence and pattern of hepatic iron deposition are associated with distinct histological features in patients with NAFLD and may have implications for pathophysiology and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Self-citationHepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Self-citationNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 4×
“2-4 (20 ) 213 (38) 22 (35) 44 (48) 53 (38)”
InfluentialSzczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Interleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983
George, D. K., Goldwurm, S., Macdonald, G. A., Cowley, L. L., Walker, N. I., Ward, P. J., Jazwinska, E. C., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70482-2 · Cited by 659
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614
Regulation of hepcidin transcription by interleukin-1 and interleukin-6
Lee, P., Peng, H., Gelbart, T., Wang, L., & Beutler, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409808102 · Cited by 543
Bekri, S., Gual, P., Anty, R., Luciani, N., Dahman, M., Ramesh, B., Iannelli, A., Staccini–Myx, A., Casanova, D., Ben Amor, I., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.007 · Cited by 496
Bugianesi, E., Manzini, P., D'Antico, S., Vanni, E., Longo, F., Leone, N., Massarenti, P., Piga, A., Marchesini, G., & Rizzetto, M. (2004) · Hepatology · doi:10.1002/hep.20023 · Cited by 440
The Molecular Mechanism of Hepcidin-mediated Ferroportin Down-Regulation
De Domenico, I., Ward, D. M., Langelier, C., Vaughn, M. B., Nemeth, E., Sundquist, W. I., Ganz, T., Musci, G., & Kaplan, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0060 · Cited by 434
Bonkovsky, H. L., Jawaid, Q., Tortorelli, K., LeClair, P., Cobb, J., Lambrecht, R. W., & Banner, B. F. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80032-4 · Cited by 360
Goswami, T., & Andrews, N. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600197200 · Cited by 352 · cited 1×
“04 Insulin (lU/mL) 19 (13-29) 16 (11-24) 23 (12-32) 18 (12-23) 0.”
The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression
Schmidt, P. J., Toran, P. T., Giannetti, A. M., Bjorkman, P. J., & Andrews, N. C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.016 · Cited by 345
Gao, J., Chen, J., Kramer, M., Tsukamoto, H., Zhang, A.-S., & Enns, C. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.010 · Cited by 326
ER Stress Controls Iron Metabolism Through Induction of Hepcidin
Vecchi, C., Montosi, G., Zhang, K., Lamberti, I., Duncan, S. A., Kaufman, R. J., & Pietrangelo, A. (2009) · Science · doi:10.1126/science.1176639 · Cited by 310 · cited 2×
“AST (U/L) 45 (32-68) 40 (31-56) 58 (39-77) 45 (33-63) 0.”
Valenti, L., Fracanzani, A. L., Dongiovanni, P., Bugianesi, E., Marchesini, G., Manzini, P., Vanni, E., & Fargion, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01192.x · Cited by 290
Valenti, L., Fracanzani, A. L., Bugianesi, E., Dongiovanni, P., Galmozzi, E., Vanni, E., Canavesi, E., Lattuada, E., Roviaro, G., Marchesini, G., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.013 · Cited by 281
Chalasani, N., Wilson, L., Kleiner, D. E., Cummings, O. W., Brunt, E. M., & Ünalp, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.016 · Cited by 253
Self-citationChitturi, S., Weltman, M., Farrell, G. C., McDonald, D., Liddle, C., Samarasinghe, D., Lin, R., Abeygunasekera, S., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33892 · Cited by 247
Hepatic iron and nonalcoholic fatty liver disease
Younossi, Z. M., Gramlich, T., Bacon, B. R., Matteoni, C. A., Boparai, N., O'Neill, R., & McCullough, A. J. (1999) · Hepatology · doi:10.1002/hep.510300407 · Cited by 238
Facchini, F. S., Hua, N. W., & Stoohs, R. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32403 · Cited by 233
Sumida, Y., Nakashima, T., Yoh, T., Furutani, M., Hirohama, A., Kakisaka, Y., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Okanoue, T., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00331-8 · Cited by 215
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease
Aigner, E., Theurl, I., Theurl, M., Lederer, D., Haufe, H., Dietze, O., Strasser, M., Datz, C., & Weiss, G. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1374 · Cited by 190
Pathology of hepatic iron overload
Deugnier, Y. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4755 · Cited by 185
Sorrentino, P., D’Angelo, S., Ferbo, U., Micheli, P., Bracigliano, A., & Vecchione, R. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.011 · Cited by 183
Classification and diagnosis of iron overload.
Piperno, A. (1998) · PubMed · Cited by 173
Metals, Oxidative Stress, and Hepatic Fibrogenesis
Pietrangelo, A. (1996) · Seminars in Liver Disease · doi:10.1055/s-2007-1007215 · Cited by 166
Iron overload syndromes and the liver
Batts, K. P. (2007) · Modern Pathology · doi:10.1038/modpathol.3800715 · Cited by 162
Signaling Role of Intracellular Iron in NF-κB Activation
Xiong, S., She, H., Takeuchi, H., Han, B., Engelhardt, J. F., Barton, C. H., Zandi, E., Giulivi, C., & Tsukamoto, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210905200 · Cited by 161
Otogawa, K., Kinoshita, K., Fujii, H., Sakabe, M., Shiga, R., Nakatani, K., Ikeda, K., Nakajima, Y., Ikura, Y., Ueda, M., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060441 · Cited by 157
Oxidative stress-mediated hepatotoxicity of iron and copper: Role of Kupffer cells
Videla, L. A., Fernández, V., Tapia, G., & Varela, P. (2003) · BioMetals · doi:10.1023/a:1020707811707 · Cited by 141
Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents.
Pietrangelo, A., Gualdi, R., Casalgrandi, G., Montosi, G., & Ventura, E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117861 · Cited by 137
Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages
Lin, M., Rippe, R. A., Niemelä, O. J., Brittenham, G. M., & Tsukamoto, H. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.6.g1355 · Cited by 133
Nelson, J. E., Bhattacharya, R., Lindor, K. D., Chalasani, N., Raaka, S., Heathcote, J., Miskovsky, E. P., Shaffer, E. A., Rulyak, S. J., & Kowdley, K. V. (2007) · Hepatology · doi:10.1002/hep.21742 · Cited by 122
Self-citationIron activates NF-κB in Kupffer cells
She, H., Xiong, S., Lin, M., Zandi, E., Giulivi, C., & Tsukamoto, H. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00108.2002 · Cited by 121
Hepatic stellate cell activation in genetic haemochromatosis
Ramm, G. A., Crawford, D. H., Powell, L. W., Walker, N. I., Fletcher, L. M., & Halliday, J. W. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80424-2 · Cited by 113
Iron Accumulation in Alcoholic Liver Diseases
Kohgo, Y., Ohtake, T., Ikuta, K., Suzuki, Y., Hosoki, Y., Saito, H., & Kato, J. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000189274.00479.62 · Cited by 98
FAMILIAL HEMOCHROMATOSIS: CHARACTERISTICS OF THE PRE-CIRRHOTIC STAGE IN A LARGE KINDRED
Rowe, J. W., Wands, J. R., Mezey, E., Waterbury, L. A., WRIGHT, J. R., Tobin, J., & Andres, R. (1977) · Medicine · doi:10.1097/00005792-197705000-00002 · Cited by 92
Iron-dependent activation of NF-κB in Kupffer cells: a priming mechanism for alcoholic liver disease
Xiong, S., She, H., Sung, C. K., & Tsukamoto, H. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00100-9 · Cited by 82
Pathology of Hepatic Iron Overload
Brunt, E. M. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923311 · Cited by 68
Self-citationThe Role of Iron in the Pathophysiology and Treatment of Chronic Hepatitis C
Price, L., & Kowdley, K. V. (2009) · Canadian Journal of Gastroenterology · doi:10.1155/2009/290383 · Cited by 65
Self-citationHouglum, K., Bédossa, P., & Chojkier, M. (1994) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1994.267.5.g908 · Cited by 65
Stå, P., Broomé, U., Scheynius, A., Befrits, R., & Hultcrantz, R. W. (1995) · Hepatology · doi:10.1002/hep.1840210514 · Cited by 49
Pietrangelo, A., Montosi, G., Garuti, C., Contri, M. B., Giovannini, F., Ceccarelli, D., & Masini, A. (2002) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1013874804911 · Cited by 44
Valenti, L. V. C., Fracanzani, A. L., & Fargion, S. R. (2003) · Gastroenterology · doi:10.1053/gast.2003.50130 · Cited by 42
Signaling role of iron in NF-kappa B activation in hepatic macrophages
Xiong, S., She, H., & Tsukamoto, H. (2004) · Comparative Hepatology · doi:10.1186/1476-5926-2-s1-s36 · Cited by 32
Iron in hepatitis C: villain or innocent bystander?
Ioannou, G. N., Tung, B. Y., & Kowdley, K. V. (2002) · PubMed · Cited by 25
Self-citationThe Role of Iron in Nonalcoholic Fatty Liver Disease: The Story Continues
Kowdley, K. V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.023 · Cited by 21
Self-citationRamm, G. A., Powell, L. W., Fletcher, L. M., et al. (1995) · Hepatology · Cited by 10
Cited by
Kowdley, K. V., Belt, P., Wilson, L. A., Yeh, M. M., Neuschwander–Tetri, B. A., Chalasani, N., Sanyal, A. J., & Nelson, J. E. (2012) · Hepatology · doi:10.1002/hep.24706 · Cited by 543
Self-citationTsurusaki, S., Tsuchiya, Y., Koumura, T., Nakasone, M., Sakamoto, T., Matsuoka, M., Imai, H., Yuet-Yin Kok, C., Okochi, H., Nakano, H., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1678-y · Cited by 529
Oxidative Stress in Liver Pathophysiology and Disease
Allameh, A., Niayesh-Mehr, R., Aliarab, A., Sebastiani, G., & Pantopoulos, K. (2023) · Antioxidants · doi:10.3390/antiox12091653 · Cited by 514
Wong, V. W.-S., Chu, W. C.-W., Wong, G. L.-H., Chan, R. S.-M., Chim, A. M.-L., Ong, A., Yeung, D. K.-W., Yiu, K. K.-L., Chu, S. H.-T., Woo, J., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300342 · Cited by 491
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Takahashi, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15539 · Cited by 486
Metadata
- Authors
- Nelson, J. E., Wilson, L., Brunt, E. M., Yeh, M. M., Kleiner, D. E., Unalp-Arida, A., & Kowdley, K. V.
- Venue
- Hepatology
- Published
- 2010-11-29
- Volume
- 53
- Issue
- 2
- Pages
- 448-457
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2006999442
- Cited by
- 356
- References
- 51
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.